首页> 外文期刊>Vascular pharmacology >Coronary action of endothelin-1 and vasopressin during acute hypertension in anesthetized goats. Role of nitric oxide and prostanoids.
【24h】

Coronary action of endothelin-1 and vasopressin during acute hypertension in anesthetized goats. Role of nitric oxide and prostanoids.

机译:麻醉山羊急性高血压过程中内皮素-1和加压素的冠状作用。一氧化氮和前列腺素的作用。

获取原文
获取原文并翻译 | 示例
       

摘要

Coronary reactivity to endothelin-1 and vasopressin during acute, moderate hypertension, and the role of nitric oxide (NO) and prostanoids in this reactivity was examined in anesthetized goats. Left circumflex coronary flow was electromagnetically measured, and hypertension was induced by constriction of the thoracic aorta in animals nontreated (7 goats) or treated with the inhibitor of NO synthesis N(w)-nitro-l-arginine methyl esther (l-NAME, 6 goats) or the cyclooxygenase inhibitor meclofenamate (6 goats). Under normotension (19 animals), basal mean values for mean arterial pressure and coronary vascular conductance (CVC) were 89+/-3 mm Hg and 0.36+/-0.038 ml/min/mm Hg, respectively. Endothelin-1 (0.01-0.3 nmol) and vasopressin (0.03-1 mug) dose-dependently decreased CVC, which, for endothelin-1 ranged from 5+/-1% (0.01 nmol; P<0.01) to 66+/-4% (0.3 nmol; P<0.001) and for vasopressin ranged from 9+/-1% (0.03 mug P<0.01) to 41+/-3% (1 mug; P<0.001). During nontreated and treated hypertension, mean arterial pressure increased to approximately 130 mm Hg (P<0.01), and CVC decreased (17%) only during l-NAME-treated hypertension. The effects of endothelin-1 and vasopressin on CVC were decreased by approximately 50% during nontreated hypertension, and this was abolished by l-NAME and was not affected by meclofenamate. Therefore, during acute, moderate hypertension, the coronary vasoconstriction to endothelin-1 and vasopressin is attenuated, which may be related with increased NO release but not with prostanoids.
机译:在麻醉的山羊中检查了急性,中度高血压期间对内皮素-1和血管加压素的冠状反应,以及一氧化氮(NO)和前列腺素在该反应中的作用。用电磁方法测量左旋支冠状动脉血流量,并通过未处理(7只山羊)或用NO合成抑制剂N(w)-硝基-1-精氨酸甲基醚(l-NAME)的胸主动脉收缩诱发高血压。 6只山羊)或环氧合酶抑制剂甲氯芬那酸酯(6只山羊)。在常压下(19只动物),平均动脉压和冠状动脉血管导度(CVC)的基础平均值分别为89 +/- 3 mm Hg和0.36 +/- 0.038 ml / min / mm Hg。内皮素-1(0.01-0.3 nmol)和血管加压素(0.03-1马克杯)剂量依赖性降低CVC,内皮素-1的CVC范围为5 +/- 1%(0.01 nmol; P <0.01)至66 +/- 4%(0.3 nmol; P <0.001)和加压素的范围从9 +/- 1%(0.03杯P <0.01)到41 +/- 3%(1杯; P <0.001)。在未经治疗和治疗的高血压期间,仅在以l-NAME治疗的高血压期间,平均动脉压增加至约130 mm Hg(P <0.01),而CVC降低(17%)。在未经治疗的高血压期间,内皮素-1和加压素对CVC的作用降低了约50%,并且被l-NAME取消,并且不受甲氯芬那酸酯的影响。因此,在急性,中度高血压期间,对内皮素-1和加压素的冠状动脉血管收缩作用减弱,这可能与NO释放增加有关,而与前列腺素无关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号